Purine derivatives as liver X receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S263220, C514S263230, C514S263340, C514S263350, C514S263300, C544S267000, C544S269000, C544S272000

Reexamination Certificate

active

07495004

ABSTRACT:
The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cardiovascular disease and atherosclerosis, novel compounds of formula (I) for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.

REFERENCES:
patent: 2928833 (1960-03-01), Leake et al.
patent: 4883801 (1989-11-01), Nathanson
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5157026 (1992-10-01), Chakravarty et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5332744 (1994-07-01), Chakravarty et al.
patent: 5374638 (1994-12-01), Dhanoa et al.
patent: 5409934 (1995-04-01), Smith et al.
patent: 5412097 (1995-05-01), Chakravarty et al.
patent: 5461059 (1995-10-01), Bonnet et al.
patent: 5470579 (1995-11-01), Bonte et al.
patent: 5641784 (1997-06-01), Kufner-Muhl et al.
patent: 5714494 (1998-02-01), Connell et al.
patent: 5719279 (1998-02-01), Kufner-Muhl et al.
patent: 6187780 (2001-02-01), Blech et al.
patent: 6316503 (2001-11-01), Hasegawa et al.
patent: 6821978 (2004-11-01), Chackalamannil et al.
patent: 7074923 (2006-07-01), Dahanukar et al.
patent: 7192952 (2007-03-01), Kanstrup et al.
patent: 2006/0205711 (2006-09-01), Himmelsbach et al.
patent: 2062558 (1992-03-01), None
patent: 4325254 (1994-02-01), None
patent: 400974 (1990-12-01), None
patent: 430300 (1991-06-01), None
patent: WO 92/05175 (1992-04-01), None
patent: WO 92/05176 (1992-04-01), None
patent: WO 92/11260 (1992-07-01), None
patent: WO 93/23401 (1993-11-01), None
patent: WO 94/03456 (1994-02-01), None
patent: WO 94/20460 (1994-09-01), None
patent: WO 99/36073 (1999-07-01), None
patent: WO 00/09507 (2000-02-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 01/34610 (2001-05-01), None
patent: WO 01/60824 (2001-08-01), None
patent: WO 01/68600 (2001-09-01), None
patent: WO 02/02560 (2002-01-01), None
patent: WO 02/24632 (2002-03-01), None
patent: WO 02/24698 (2002-03-01), None
patent: WO 02/067942 (2002-09-01), None
patent: WO 02/068420 (2002-09-01), None
patent: WO 03/004496 (2003-01-01), None
Samura et al., Pharmaceutical Chemistry Journal vol. 20, No. 1 Jan. 1986 pp. 37-40.
Collins, J.L., et al. “Identification of a Nonsteroidal Liver X Receptor Agonist Through Parallel Array Synthesis of Tertiary Amines.” Journal of Medicinal Chemistry, American Chemical Society. Vo. 45, 2002, pp. 1963-1966.
Chlon, G et al.; Synthesis, 5-HT1A and 5-HT2A Receptor Activity of New 1-Phenylpiperazinylpropyl Derivatives with Arylakyl Substituents in Position 7 of Purine-2,6-Dione; Pol J Pharm: 2001; 53/4; 359-368; Polish Academy of Sciences, Institute of Pharmacology.
Pozharskii, AF, et al.; N-Anions of Heteroarymatic Amines,; Khlm Geterotslkt Soedln (Russian); 1971; 7/9; 1230-1237, abstract only.
Priimenko, BA et al.; Synthesis and Physicochemical Properties of 7,8-Disubstituted 3-Methylxanthine and 2,6,7,8-tetrasubstituted Purine; Izvestiya Vysshikh Uchebnykh Zavedenii, Khimiya i Khimicheskaya Tekhnologiya; 1986; 29/2; 35-38; (Russian), Abstract only.
Romanenko, NI, et al.; Reactions of 7-Substituted 8-bromo-3-methylxanthine with some Electrophilic and Nucleophilic Reagents; Ukr. Khim. Zh. (Russian); 1987; 53/9; 983-986, Abstract only.
Romanenko, NI, et al.; Synthesis and Antibacterial and Antifungal Activity of Some 3-methyl-8-nitroxanthine Derivatives; Khimiko-Farmatsevticheskii Zhurnal; 1997; 31/4; 28-29, Abstract only.
Bolte, M. “Nearly Centrosymmetric (S)-7-(2,6-dichlorobenzyl)-8-(3-oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione.” Acta Cryst, Sect. C, 1996, C52(8), pp. 1985-1987.
Drabczynska, A., et al. “Structure and Activity Studies of Glycine Receptor Ligands. Part 4. N-[(7-arylalkyl,7-aryloxyalkyl)-8-theophyllyl]-glycines.” Pol. J. chem.., 1999, 73(5), pp. 783-792.
Drabczynska, A., et al. “Synthesis and preliminary Pharmacological Screening of Some 8-Substituted Methylxanthines.” Pol. J. Pharmacol. Pharm., 1989, 41(4), pp. 385-394.
Jarymowicz, B. “Pochodne 1,3-Dimetylo-8-Formylo-7-Podstawione Ksantyny W Syntezie Hantzscha.” ACTA Polon. Pharm. XXXVIII, No. 2, 1981, pp. 201-205.
Mosselhi, M.A.N., et al. “Synthesis and Properties of 8-nitro-7-alkylated Theophylline Derivatives.” Bull. Pol. Acad. Sci., Chem., 1994, 41(30, pp. 179-185.
Mosselhi, M.A.N., et al. “Synthesis and Properties of 8-nitro-7-alkylated Theophylline Derivatives.” J. Serb. Chem.. Soc., 1993, 58(7-8), pp. 499-505.
Van Muijlwijk-Koezen, J.E., et al. “synthesis and use of FSCPX, an Irreversible Adenosine A1 Antagonists, As a ‘Receptor Knock-Down’ Tool.” Bioorganic & Medicinal Chemistry Letters, 2001, 11, pp. 815-818.
ChemCats Database, Accession No. 2001:1002466.
ChemCats Database, Accession No. 2001:954502.
ChemCats Database, Accession No. 2001:950360.
ChemCats Database, Accession No. 2001:403692.
ChemCats Database, Accession No. 2001:115710.
ChemCats Database, Accession No. 2001:700909.
ChemCats Database, Accession No. 2001:481318.
ChemCats Database, Accession No. 2001:480523.
ChemCats Database, Accession No. 2001:477895.
ChemCats Database, Accession No. 2001:473970.
ChemCats Database, Accession No. 2001:403815.
ChemCats Database, Accession No. 2001:403693.
ChemCats Database, Accession No. 2001:403688.
ChemCats Database, Accession No. 2001:403681.
ChemCats Database, Accession No. 2001:294351.
ChemCats Database, Accession No. 2001:294343.
ChemCats Database, Accession No. 2001:294124.
ChemCats Database, Accession No. 2001:115711.
ChemCats Database, Accession No. 2001:1022442.
ChemCats Database, Accession No. 2001:1021391.
HCAPLUS Database, Accession No. 1998:100946.
HCAPLUS Database, Accession No. 1990:604407.
HCAPLUS Database, Accession No. 1987:50153.
HCAPLUS Database, Accession No. 2002:38476.
Registry Database, Registry No. 354133-04-3.
Registry Database, Registry No. 354132-96-0.
Registry Database, Registry No. 354132-95-9.
Registry Database, Registry No. 327098-61-3.
Registry Database, Registry No. 327097-83-6.
Registry Database, Registry No. 304878-88-4.
Registry Database, Registry No. 5429-50-5.
CAPLUS Database, Accession No. 1988:186421 (abstract only).
CAPLUS Database, Accession No. 1981:620045 (abstract only).
CAPLUS Database, Accession No. 1972:25126 (abstract only).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Purine derivatives as liver X receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purine derivatives as liver X receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives as liver X receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4073890

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.